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High-throughput, cell-based assays require small
sample volumes to reduce assay costs and to allow
for rapid sample manipulation. However, further min-
iaturization of conventional microtiter plate technol-
ogy is problematic due to evaporation and capillary
action. To overcome these limitations, we describe
droplet-based microfluidic platforms in which cells
are grown in aqueous microcompartments sepa-
rated by an inert perfluorocarbon carrier oil. Synthe-
sis of biocompatible surfactants and identification of
gas-permeable storage systems allowed human
cells, and even a multicellular organism (C. elegans),
to survive and proliferate within the microcompart-
ments for several days. Microcompartments contain-
ing single cells could be reinjected into a microfluidic
device after incubation to measure expression
of a reporter gene. This should open the way for
high-throughput, cell-based screening that can use
>1000-fold smaller assay volumes and has 5003
higher throughput than conventional microtiter plate
assays.
INTRODUCTION
Miniaturization has been the feature that has enabled many of
the most dramatic technological developments in recent de-
cades. In electronics, the number of transistors per integrated
circuit has roughly doubled every 2 yr since their invention in
1961. Miniaturization in biology and chemistry, although impor-
tant, has been much less dramatic. Reaction volumes have typ-
ically been reduced from a few milliliters (in test tubes) to a few
microliters (in microtiter plates)—a reduction of only 1000-fold.
Nevertheless, today, high-throughput screening (HTS) programs
can process up to 100,000 compounds per d (1 s1). Unfortu-
nately, there is little scope for further miniaturization of microtiter-
plate technology due to evaporation and capillary action causing
‘‘wicking’’ and bridging of liquid between wells (Dove, 1999).Chemistry & BiologyA promising approach to overcome these limitations is to use
microfluidic systems, which consist of networks of channels of
typically 10–100 mm diameter. Small quantities of reagents can
be brought together in a specific sequence, mixed, and allowed
to react for a specified time in a controlled region of the channel
network by using electrokinetic and/or hydrodynamic pumping
(Li and Harrison, 1997; Lin et al., 2001). They are being devel-
oped for use in several areas, allowing, for example, protein
purification, DNA separation, and PCR on a drastically de-
creased scale (Hawtin et al., 2005; Wang, 2002). The ability to
rapidly fabricate microfluidic devices in poly(dimethylsiloxane)
(PDMS) by using soft lithography (Squires and Quake, 2005)
has greatly stimulated the development of microfluidic systems.
It has even enabled sophisticated microfluidic arrays containing
thousands of compartments separated by valves (Thorsen et al.,
2002).
Even though commercial microfluidic lab-on-a-chip systems
already represent a serious competing technology for 1536-
well plates for certain types of screen, the laminar flow in micro-
fluidic devices creates two problems (Song et al., 2003). First,
mixing is slow; second, the concentration of reagents changes
continuously in the microchannels due to diffusion and the para-
bolic flow profile. Additionally, crosscontamination can create
serious problems. These problems can be overcome by using
systems in which the individual assays are compartmentalized
in aqueous microdroplets, separated by immiscible oil. Non-
microfluidic systems based on the compartmentalization of re-
actions in aqueous microdroplets of water-in-oil (w/o) emulsions
were originally developed for directed evolution and have since
been applied in a number of areas (Tawfik and Griffiths, 1998;
Kelly et al., 2007; Griffiths and Tawfik, 2006), including ultra-
high-throughput sequencing (Margulies et al., 2005; Shendure
et al., 2005). However, making and manipulating droplets in
two-phase (droplet-based) microfluidic systems allows for a level
of control of picoliter scale biochemical assays that was hitherto
impossible. Highly monodisperse (<3% polydispersity) w/o
drops can be generated at frequencies greater than 10 kHz
(Umbanhowar et al., 2000; Thorsen et al., 2001; Anna et al.,
2003). Furthermore, the aqueous microdroplets can be fused
or subdivided (Link et al., 2004, 2006; Ahn et al., 2006), the
contents of microdroplets can be mixed rapidly, and sorting15, 427–437, May 2008 ª2008 Elsevier Ltd All rights reserved 427
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Cells in Dropsmodules allow for the specific enrichment of microdroplets
(Song et al., 2003; Link et al., 2006; Ahn et al., 2006). Droplet-
based microfluidic systems based on the formation of arrays of
plugs (droplets that fill the microfluidic channels) have also
been developed (Chen and Ismagilov, 2006). Each aqueous
sample plug is stored in a holding component (e.g., a piece of
tubing or a capillary) and is spaced by a second immiscible liquid
or gas. In this way, microcompartments can be generated and
stably separated without the use of any surfactant.
Droplet-based microfluidic systems have been used for
a range of different applications, including single-molecule
PCR, proteome analysis, clinical diagnosis on human physiolog-
ical fluids, protein crystallization, and titration of anticoagulants
(Beer et al., 2007; Wheeler et al., 2005; Srinivasan et al., 2004;
Chen and Ismagilov, 2006; Song et al., 2006). They have also
been used to encapsulate prokaryotic and eukaryotic cells
(Martin et al., 2003; Grodrian et al., 2004; Sakai et al., 2005; He
et al., 2005; Oh et al., 2006; Huebner et al., 2007), and even
the embryos of multicellular organisms (Funfak et al., 2007).
However, neither the incubation and/or recovery of viable mam-
malian cells nor a full life cycle of an encapsulated multicellular
organism was demonstrated. Furthermore, none of those
systems allowed for an automated analysis of individual com-
partments subsequent to an incubation period as required for
high-throughput, cell-based assays.
We present here two complementary droplet-based microflu-
idic platforms that allow fully viable human cells to be recovered
with high yield after several days in microcompartments. The vol-
ume of each microcompartment can be over 1,000-fold smaller
than the smallest volumes utilizable in microtiter-plate-based
assays, and single or multiple human cells, as well as multicellu-
lar organisms such as C. elegans, can be compartmentalized
and can replicate in these systems. To prove the utility of this
approach for cell-based assays, we also demonstrate auto-
mated fluorescence-based analysis of single cells in individual
compartments after 16 hr of incubation.
RESULTS
Emulsion-Based Encapsulation
The ultimate goal of this study was to set up microfluidic plat-
forms for high-throughput, cell-based assays. Hence, the tech-
nology should allow for (1) Encapsulation of a predefined number
of cells per microcompartment (with the option of encapsulating
single cells being highly desirable), (2) storage of the compart-
mentalized samples within a CO2 incubator, and (3) recovery of
the cells from the compartments in a way that does not abolish
cell viability.
The encapsulation step (Figures 1A and 1B; Movie S1, see the
Supplemental Data available with this article online) was per-
formed on a PDMS chip in which 660 pl drops (corresponding
to a spherical diameter of 100 mm ± 1.7%) were created from
a continuous aqueous phase by ‘‘flow focusing’’ with a perfluori-
nated carrier oil (Anna et al., 2003). Perfluorocarbon oils are
perfectly suited for this purpose, since they are compatible
with PDMS devices, immiscible with water, transparent (allowing
for optical readout procedures), and have been shown to facili-
tate respiratory gas delivery to both prokaryotic and eukaryotic
cells in culture (Lowe et al., 1998). The number of cells per428 Chemistry & Biology 15, 427–437, May 2008 ª2008 Elsevier LtdFigure 1. Encapsulation of Jurkat Cells into Aqueous Microdrops of
a Water-in-Oil Emulsion
(A) Design of the microfluidic chip (main channels were 75 mm deep and 100
mm wide). The red rectangle indicates the section shown in (B), in which the
drops are generated by flow focusing.
(B) Encapsulation of single Jurkat cells (highlighted by red circles) into 660 pl
droplets at a frequency of 800 Hz. White bar, 100 mm.
(C) On-chip dilution of the cell-suspension allows for the controlled encapsu-
lation of single cells (here: Jurkat cells). The experimentally determined
probability (p, y axis) for the number of cells per drop (k, x axis) is in good
agreement with a Poisson distribution (dashed lines) for various cell densities
(resulting from on-chip dilution). Inset: the average number of cells per drop (l)
plotted against the cell density for the experimental data (Exp.) and the Pois-
son distribution (Fit). The dashed line is the theoretical number of cells per
drop according to the cell density only (homogeneously distributed).All rights reserved
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Cells in Dropsdroplet was controlled by using on-chip dilution of the cells to
regulate the cell density (Figure 1C): a culture of Jurkat cells,
with an initial density of 5 3 106 cells/ml, was brought together
with a stream of sterile medium by co-flow immediately before
drop formation, and the relative flow rates of the cell suspension
and the medium were changed, whereas the sum of the two flow
rates was kept constant. The number of cells per drop (k) was
always in good agreement with a Poisson distribution, and
high cell densities at the nozzle (R2.5 3 106 cells/ml) made the
encapsulation of multiple cells per drop highly likely (p > 30%).
In contrast, cell densities of 1.25 3 106 cells/ml and below
resulted in low probabilities (p % 7%) for the encapsulation of
more than one cell per drop (while increasing the probability of
finding drops without any cells inside). At the same time, the av-
erage number of cells per drop (l) decreased from approximately
2 (at 5 3 106 cells/ml) to far below 1 (at% 1.25 3 106 cells/ml).
Hence, the number of cells per drop can easily be regulated,
even allowing for the compartmentalization of single cells.
The generation of stable drops requires the use of a surfactant
that decreases the surface tension and, which for the encapsu-
lation of cells, also has to be biocompatible. For this reason, we
synthesized several perfluoropolyether-derived surfactants
(PFPE surfactants) and tested their effect on long-term cell sur-
vival (Figure 2). The surfactants differed solely in their hydrophilic
head groups, which should be the only part of the molecule in
contact with the encapsulated cells. The common perfluorinated
tail should be dissolved in the carrier oil and thus be oriented
away from the cells. To analyze the biocompatibility, we seeded
HEK293T cells on top of a perfluorocarbon oil layer in the pres-
ence (0.5% w/w) and absence of different surfactants. In the
absence of any surfactant, the cells retained an intact morphol-
ogy and even proliferated, whereas the ammonium salt of
carboxy-PFPE (Johnston et al., 1996) and poly-L-lysine-PFPE
(PLL-PFPE) mediated cell lysis. However, polyethyleneglycol-
PFPE (PEG-PFPE) and dimorpholinophosphate-PFPE (DMP-
PFPE) showed good biocompatibility, did not affect the integrity
of the cellular membrane, and even allowed for cell proliferation.
Since DMP-PFPE generated more stable emulsions than PEG-
PFPE (data not shown), it was used for all further experiments.
As the next step, procedures allowing for the recovery of
encapsulated cells had to be established. Addition of 15% (v/v)
Emulsion Destabilizer A104 (RainDance Technologies) to the
emulsions mediated reliable breaking without an obvious impact
on cell viability. This allowed for the determination of the survival
rates of suspension (Jurkat) and adherent (HEK293T) cells for
different incubation times within drops. For this purpose, we en-
capsulated cells at a density corresponding to an average of less
than 1 cell per 660 pl drop (1.25 3 106 cells/ml at the nozzle, re-
sulting in a l value of 0.55 and single cells in 31.7% of all
drops) and collected the resulting emulsions in 15 ml centrifuga-
tion tubes. After different incubation times at 37C within a CO2
incubator, the emulsions were broken and the cells were treated
with a live/dead stain to determine the survival rate and the total
number (live and dead) of recovered cells (Figures 3A and 3C).
During the first 4 d, the fraction of recovered viable Jurkat cells
did not change significantly and was always in excess of 79%.
Then, the percentage of live cells decreased from 71% after 5 d
to 32% after 6 d and finally to 1% after 14 d of encapsulation.
The total number of recovered cells divided by the number ofChemistry & BiologyFigure 2. Surfactants Used to Generate the Emulsions
For each surfactant, the chemical structure and the results of the biocom-
patibility assay (microscopical bright-field images) are shown. For the as-
say, HEK293T cells were incubated for 48 hr on a layer of perfluorinated
FC40 oil in the presence or absence (control) of the indicated surfactant
(0.5% w/w).15, 427–437, May 2008 ª2008 Elsevier Ltd All rights reserved 429
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430 Chemistry & Biology 15, 427–437, May 2008 ª2008 Elsevier Ltdinitially encapsulated cells (equal to the aqueous flow rate multi-
plied by the injection time multiplied by the cell density at the
nozzle) was defined as the recovery rate and increased from
29% after 1 hr to more than 55% after 2 d. This indicates
some degree of proliferation within the drops, which is also sup-
ported by the fact that after 24 hr the percentage of dead cells
was lower than after 1 hr. During further incubation within drops,
the recovery rates slowly decreased to just 14% after 14 d. This
decrease can be explained by the fact that dead cells ultimately
disintegrate (after several days) and thus cannot be stained any-
more. This effect is well known and has been analyzed in detail
for bacterial cells (Villarino et al., 2000). However, early time
points and the live stain are not affected by this phenomenon.
When repeating the experiments with adherent HEK293T cells,
similar results were obtained (Figures 3B and 3C). During the first
2 d, the fraction of recovered viable cells remained constant at
more than 90% before slowly decreasing to 58% after 5 d and
39% after 9 d. Finally, after 14 d of encapsulation, 28% of the re-
covered cells were still alive. The total recovery rate increased
slightly from 20% after 1 hr to more than 32% after 2 d. During
further incubation within drops, the recovery rates slowly
decreased to 23% after 14 d. The longer cell survival compared
to Jurkat cells is most likely explained by slower proliferation,
resulting in slower consumption of the available nutrition. Recov-
ered cells could also be recultivated (instead of stained) after
incubation for 2 d within droplets, resulting in normally proliferat-
ing cells (Figure 3E).
In an additional experiment, we assessed the effect of the cell
density on the survival rates. For this purpose, we used 5- and
10-fold higher densities of Jurkat cells than used initially. Com-
parison of the cell survival after 3 d showed that the cell density
inversely correlated with the survival rate (Figure 3D). Whereas
almost 90% of viable cells were recovered by using the initial
cell density, only 80% and 68%, respectively, survived for the
5- and 10-fold increased cell density. Insufficient gas exchange
can be ruled out, since equally dense cultures in ordinary tissue-
culture flasks did not survive longer: using a density equal to 1
cell in a 660 pl drop (1.5 3 106 cells/ml), the number of viable
Jurkat cells remained above 87% for the first 2 d, before
decreasing to 51% after 4 d and 0% after 9 d (data not shown).
Therefore, we conclude that the encapsulated cells most likely
die due to the lack of nutrition or the accumulation of toxic me-
tabolites, not because of compartmentalization-specific factors
such as the oil and surfactant.
Plug-Based Encapsulation
In parallel to encapsulating cells into aqueous drops of a w/o
emulsion, we established a system in which aqueous plugs
spaced by immiscible oil within a piece of tubing serve as
Figure 3. Cell Viability, Recovery, and Recultivation of Cells Encap-
sulated in 660 pl Drops
(A and B) The percentage of viable (A) Jurkat and (B) HEK293T cells recovered
from emulsions at the indicated time points.
(C) The total number of recovered Jurkat and HEK293T cells (live and dead)
relative to the number of initially encapsulated cells.
(D) The percentage of viable Jurkat cells encapsulated at different densities
after 3 d.
(E) Recultivation of HEK293T cells recovered after 48 hr of encapsulation.
Error bars show the standard deviation of three independent experiments.All rights reserved
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Cells in Dropsa culture vessel. This approach allows for the generation of aque-
ous microcompartments big enough to host small cell popula-
tions and even multicellular organisms. This cannot be achieved
by simply increasing the drop size of a given emulsion. First, the
maximum size of a drop generated on a microfluidic chip is lim-
ited by the channel dimensions. Second, as the size of the drops
increases, they become less stable, resulting in uncontrolled
sample coalescence. These problems can be circumvented by
alternately aspirating aqueous plugs and immiscible oil into
a holding cartridge (e.g., a capillary or a piece of tubing) (Chen
and Ismagilov, 2006). We used this approach to encapsulate
several thousand cells into single microcompartments.
First, we assessed holding cartridges made of different mate-
rials for their suitability to host living cells. For this purpose, we
generated 660 nl plugs hosting 3300 Jurkat cells each. While
gas-permeable PTFE tubing allowed for cell survival for several
days, the use of glass capillaries and vinyl tubing (all with an inner
diameter of0.5 mm) resulted in cell death within 24 hr (data not
shown). Live/dead stains revealed that, when using PTFE tubing,
the survival rate of Jurkat cells remained at90% for the first 2 d,
before decreasing gradually from 69% after 3 d, to 38% after 5 d,
and finally to 6% after 14 d (Figure 4A). The total number of re-
covered cells increased from 69% after 1 hr to 194% after 5 d,
indicating roughly 1–2 cell divisions (Figure 4C). When repeating
the experiments with adherent HEK293T cells, slightly different
results were obtained (Figures 4B and 4C). Here, the fraction of
viable cells remained above 80% for the first 4 d, before slowly
decreasing to 31% after 14 d. The recovery rate increased during
the first 5 d from 83% to 147%. Recultivation experiments
demonstrated the recovery of fully viable and normally proliferat-
ing HEK293T cells after 2 d of encapsulation (Figure 4E).
To assess the influence of the cell density on cell survival, we
also performed experiments with five and ten times more Jurkat
cells per plug. Once again, we obtained an inverse correlation
between cell density and survival. Whereas 69% viable Jurkat
cells were recovered after 3 d when using the initial cell density,
only 52% and less than 1% survived when encapsulating five
and ten times more cells per plug, respectively (Figure 4D).
This massive decrease in cell survival is probably due to the
fact that higher cell densities directly resulted in more cells per
plug (even at the lowest density, all plugs were occupied),
whereas, when encapsulating single cells into drops, the propor-
tion of occupied drops was increased first (with a single cell in
a drop still experiencing the same cell density).
In addition, we analyzed if the plugs were subjected to any
evaporation during the incubation period. For this purpose, we
determined the mean length of the plugs over time by measuring
the size of 30 plugs for each time point by using a digital slide
gauge and multiplying the mean value by the inner tube diameter
to obtain the corresponding plug volumes. No significant de-
crease in size was observable (Figure 4F), most likely due to
the fact that we performed the incubation step in a water-satu-
rated atmosphere (at 37C, 5% CO2).
We also investigated the possibility of encapsulating multicel-
lular organisms. Starting with eggs of the nematode C. elegans,
we analyzed the plugs under the microscope at different time
points (Figure 5). Whereas after 2 d hatched worms had already
reached the L2–L3 larvae stage, 4 d of encapsulation resulted in
the growth of adult worms and the birth of the next generationChemistry & Biology(L1 larvae). Longer encapsulation resulted in plugs hosting up
to 20 (Movie S2) worms, which finally died after 6–9 d. The pass-
ing of individual worms into adjacent microcompartments was
never observed, even at high flow rates (up to 1000 ml/hr).
On-Chip Postincubation Analysis
of Individual Compartments
High-throughput, cell-based assays require the readout of indi-
vidual samples after the incubation step (e.g., to screen the phe-
notype of individual cells within a heterogeneous population). For
this purpose, microcompartments stored in a piece of tubing or
a reservoir have to be reinjected into an on-chip readout module
after the incubation period. To prove the feasibility of this
approach, we encapsulated HEK293T cells within 660 pl drops,
collected the resulting emulsions, and incubated the samples for
2 and 14 d. Subsequently, the emulsions were reinjected into
a chip (same design as for the encapsulation step) and were
analyzed microscopically. During reinjection of the emulsion
after 2 d of incubation, hardly any coalescence of individual sam-
ples was detectable (Figure 6A; Movie S3). After 14 d of incuba-
tion, some degree of coalescence was observable; however, the
majority of drops (>90%) remained intact. Microscopical com-
parison of the drops at the time of incubation and reinjection
revealed no obvious reduction of the drop size (Figure 6B).
This indicates that the drops are not subjected to significant
evaporation during the incubation period (within a water-satu-
rated atmosphere).
To demonstrate that the drops can be analyzed individually
after reinjection, we encapsulated a population of HEK293T cells
that, 2 wk before the experiment, had been incubated in bulk
with viral particles (murine leukemia virus pseudotyped with
the G protein of the vesicular stomatitis virus) having packaged
the lacZ gene. The fraction of cells stably expressing the corre-
sponding gene product (b-galactosidase) was 13.9%, as
determined in an X-Gal assay (Stitz et al., 2001). During the
drop production, a fluorogenic substrate (1.7 mM fluorescein
di-b-D-galactopyranoside, FDG) for b-galactosidase was coen-
capsulated into the drops, and a laser beam (488 nm wave-
length) was focused onto the channel (downstream of the
nozzle). The emitted light was collected in a photomultiplier (Fig-
ure 6D) to record the fluorescence signal at t0. This measurement
was performed with the initial population of transduced
HEK293T cells and a sample that had been diluted 1:9 with
nontransduced HEK293T cells. At the time of encapsulation,
no difference in the fluorescence signals was observable, and
even drops without any cell showed the same signal intensity
(data not shown). After an incubation time of 16 hr at 37C, the
emulsions were reinjected into the chip together with additional
fluorinated oil (separately injected into the oil inlet to space out
the drops) to repeat the fluorescence measurement (at ti; analyz-
ing 500 drops/s). Plotting the maximum fluorescence intensity of
the drops against the peak width (which corresponds to the drop
size and therefore is a good indicator of coalescence) revealed
different distinct populations (Figure 6F). Analysis of the peak
width proved that even though populations with 2-fold and
3-fold higher volumes were observable, the majority of drops
did not coalesce (>93%). In terms of the fluorescence, two
main populations with an 35-fold difference in their intensity
were obtained, as also confirmed by fluorescence microscopy15, 427–437, May 2008 ª2008 Elsevier Ltd All rights reserved 431
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Cells in DropsFigure 4. Cell Viability, Recovery, and Recultivation of Cells Encapsulated in 660 nl Plugs
(A and B) The percentage of viable (A) Jurkat and (B) HEK293T cells recovered from plugs at the indicated time points.
(C) The total number of recovered Jurkat and HEK293T cells (live and dead) relative to the number of initially encapsulated cells.
(D) The percentage of viable Jurkat cells encapsulated at different densities after 3 d.
(E) Recultivation of HEK293T cells recovered after 48 hr of encapsulation.
(F) Mean size of plugs harboring HEK293T cells plotted against the incubation time.
Error bars show the standard deviation of three independent experiments.in which the drops appeared to be either highly fluorescent or
nonfluorescent (Figure 6C). Based on these observations, we
set gates for the quantitative interpretation of the data (as rou-
tinely done in FACS analysis). Gates were set to solely analyze
those drops that had not coalesced (corresponding to the pop-
ulations with the lowest peak width). Based on the way the
peak width was defined, fluorescence-positive drops appeared
to be bigger (see Figure 6E). Nonetheless, plotting the fluores-
cence against the peak width enabled noncoalesced drops to
be clearly distinguished from coalesced drops for both species
(positives and negatives). The use of gating leads to the conclu-432 Chemistry & Biology 15, 427–437, May 2008 ª2008 Elsevier Ltdsion that 5.08% of all noncoalesced drops were fluorescence
positive in the sample with nondiluted transduced cells. This
number corresponds to 12.7% of the corresponding cell
population when taking into account that only 40.0% of the
drops were occupied (as determined by microscopical analysis
of the drops during the encapsulation step). This value is in the
same range as the fraction of positive cells determined in bulk
(13.9%), by using a conventional X-Gal assay. For the diluted
sample, we obtained 0.63% positive drops, corresponding to
1.8% of the cells (34.8% of the drops were occupied). Compared
to the nondiluted sample, the negative population showedAll rights reserved
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Cells in DropsFigure 5. Growth of the Nematode C. elegans within Aqueous 660 nl Plugs
Eggs (black arrow) were encapsulated at room temperature, and bright-field microscopical images were taken after 0, 2, or 4 d. White arrows show larvae of the
second generation of encapsulated worms. White bar, 100 mm.a lower fluorescence intensity. This is most likely due to the fact
that all drops (even the ones without cells) contain traces of
soluble b-galactosidase, resulting from the few dead cells within
the syringe (during the encapsulation step). Since the diluted
sample contains less enzyme in total, a lower background can
be expected, too. Another possible explanation would be the ex-
change of fluorescein between the drops. However, this seems
to be unlikely, since for incubation periods of up to 24 hr we never
observed any significant exchange of fluorescein for any surfac-
tants tested (including the ammonium salt of carboxy-PFPE and
PEG-PFPE; data not shown). The resulting 7.1-fold difference in
terms of positive cells between the samples is in good agree-
ment with the initial 1:9 dilution (assuming an accuracy of
±10% when counting the cultures in a Neubauer chamber before
mixing leads to the conclusion that the effective ratio might have
been as low as 1:7.4). In summary, these results clearly demon-
strate the possibility of quantitatively analyzing individual drops
in a high-throughput fashion (we analyzed the drops at a fre-
quency of 500 Hz).
DISCUSSION
We have used droplet-based microfluidic systems to create min-
iaturized reaction vessels in which both adherent and nonadher-
ent cells can survive for several days. Even though we generated
microcompartments with volumes of 660 pl and 660 nl only, in
principal almost any volume can be generated by changing the
channel sizes and flow rates, or by splitting relatively large micro-
compartments through a T-junction into smaller units (Adamson
et al., 2006). Thus, microcompartments tailored for the encapsu-
lation of small objects like single cells can be generated as well
as compartments big enough to host multicellular organisms
like C. elegans. Furthermore, the size can be adjusted according
to the assay duration. Cell density was found to inversely corre-
late with the survival time of encapsulated cells. Larger compart-
ments are hence preferential for long-term assays, especially
since encapsulated cells proliferate within the microcompart-
ments. Consequently, even proliferation assays (e.g., for screen-
ing cytostatic drugs) should be possible as long as the chosen
volume is big enough to guarantee sufficient supply of nutrition.
On the other hand, small volumes might be advantageous for
other applications, for example to minimize reagent costs or to
rapidly obtain high concentrations of secreted cellular factors.
Besides the volume, additional factors, notably the biocompati-Chemistry & Biologybility of the surfactants and the gas permeability of the storage
system, have a major impact on cell survival. Both of the nonionic
surfactants described here allowed for cell survival and prolifer-
ation, whereas the two ionic surfactants mediated cell lysis. Even
though there is no direct proof of correlation, it seemed quite
striking that poly-L-lysine, a compound widely used to improve
cell attachment to surfaces (Budd et al., 1989), mediated
membrane disruption when used as a head group of an ionic
surfactant. Long-term incubation also requires sufficient gas ex-
change. This can be ensured either by using open reservoirs or
channels or tubing made of gas-permeable materials such as
fluorinated polymers. Efficient gas exchange is also helped by
the fact that perfluorocarbon carrier fluids can dissolve more
than 20 times the amount of O2, and 3 times the amount of
CO2, than water and have been shown to facilitate respiratory
gas delivery to both prokaryotic and eukaryotic cells in culture
(Lowe et al., 1998).
The possibility of reinjecting microcompartments into a chip
after the incubation step opens the way for integrated droplet-
based microfluidic systems for cell-based HTS. As we have
shown here, a fluorescence-based readout of the expression
of a cellular reporter gene can be performed in individual
compartments at frequencies of 500 Hz. Hence, a wide range
of commercially available fluorescence-based assays (Gonzalez
and Negulescu, 1998; Sundberg, 2000) can potentially be
performed in a high-throughput fashion. The fact that possible
coalescence of individual drops does not necessarily bias the
readout is noteworthy. As shown here, coalesced drops with
higher volumes can easily be identified and excluded from the
data analysis. In theory, the use of gates also allows for the anal-
ysis of only those compartments hosting a specific number of
(fluorescent) cells. In contrast to conventional FACS analysis,
the assay readout does not have to be based on fluorophores
that remain in, or on the surface of, the cells (e.g., GFP or fluores-
cent antibodies). Using compartmentalization, we have been
able to measure the activity of an intracellular reporter enzyme
(b-galactosidase) by using a fluorescent product that is highly
membrane permeable (fluorescein).
The integration of additional microfluidic modules into the
microfluidic platforms shown here should allow the application
range to be expanded. Integrating a microfluidic sorting module
(based on dielectrophoresis or valves) (Ahn et al., 2006; Fu et al.,
2002) could, for example, enable the screening of drug candi-
dates. In the simplest case, the candidates could be genetically15, 427–437, May 2008 ª2008 Elsevier Ltd All rights reserved 433
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Cells in DropsFigure 6. Reinjection and Analysis of Emulsions after Incubation
(A) Bright-field image of the inlet during reinjection of an emulsion (drops containing HEK293T cells) after 2 d of incubation.
(B) Bright-field images of individual drops during encapsulation and after reinjection (off-chip incubation for 2 and 14 d).
(C) Fluorescence-microscopic image of drops hosting lacZ-expressing HEK293T cells (converting the fluorogenic substrate FDG) after 16 hr of incubation.
(D) Optical setup for fluorescence measurements.
(E) Influence of the fluorescence intensity (y axis) on the peak width (w). The peak width is defined as the time (t, x axis) for which a fluorescent signal above a cer-
tain threshold (dotted, horizontal line) can be measured (due to a drop passing the laser beam). Different fluorescence intensities of the drops (continuous and
dashed peaks) result in different apparent peak widths (w1 and w2).
(F) Fluorescence signals of drops after reinjection. Upper panels: fluorescence intensity (x axis) plotted against the peak width (y axis) for pure (left) and 1:9 diluted
(right) transduced cells. The relative frequency of all events is color coded according to the bar on the right (numbers corresponding to the exponent of the fre-
quency). White gates correspond to noncoalesced drops: left gate, drops considered as negatives; right gate, drops considered as positives. Lower panel: fluo-
rescence intensity (x axis) plotted against the drop counts (y axis) of all events within the gates. Positive events are depicted in red, and negative events are
depicted in black.434 Chemistry & Biology 15, 427–437, May 2008 ª2008 Elsevier Ltd All rights reserved
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Cells in Dropsencoded by the encapsulated cells themselves (starting with
a cell library); hence, the collection of sorted positive drops
would allow for the identification of hits by DNA sequencing.
Alternatively, the sorting module could be used to screen syn-
thetic compounds fixed on beads (e.g., one-bead-one-com-
pound libraries) coencapsulated in the drops. After the sorting
step, beads that mediated the desired effect could be recovered
from the drops for a subsequent decoding step (e.g., by mass
spectroscopy). Using optical barcodes encoding the compound
identity might even allow the decoding step to be performed in
real time (without the need for a sorting module) (Battersby
et al., 2002; Pregibon et al., 2007). For example, different fluores-
cence channels could be used for the assay and label readout.
The fact that the optical barcode does not even have to be
directly linked to the test compound when using droplet-based
microfluidics is noteworthy: the label can simply be mixed with
the test compound prior to the encapsulation step.
SIGNIFICANCE
Aqueous microcompartments can be used as miniaturized
vessels for chemical and biological reactions (Tawfik and
Griffiths, 1998; Kelly et al., 2007; Griffiths and Tawfik, 2006).
We show here how this approach can also be utilized for
cell-based applications. We demonstrate that human cells,
and even a multicellular organism (C. elegans), can be com-
partmentalized and remain fully viable for several days in
droplets. The microfluidic platforms described here allow
the encapsulation step to occur at rates of more than 800
per sec. As the number of cells per drop follows a Poission
distribution, the optional encapsulation of single cells
causes the generation of empty drops, thus decreasing the
resulting encapsulation rate to 300 per sec. We have dem-
onstrated postincubation fluorescence readout of individual
compartments at 500 Hz, and additional droplet manipula-
tion procedures (such as fusion, splitting, and sorting) can
be performed at similar rates (Link et al., 2004, 2006; Ahn
et al., 2006). Consequently, the throughput of a single inte-
grated, droplet-based microfluidic system for cell-based
screening could potentially be 500 times higher than con-
ventional robotic microtiter-plate-based HTS technologies
that can perform a maximum of 100,000 assays per d, or
1 s1. Using compartments as small as 660 pl, the volume
of each assay, and hence the cost of reagents for screening,
could be reduced by >1000-fold relative to the smallest as-
say volumes in microtiter plates (1–2 ml). This may allow
many high-throughput biochemical screens to be replaced
by more physiologically relevant cell-based assays (Chap-
man, 2004; Johnston and Johnston, 2002), including assays
with highly valuable cells, e.g., primary human cells, which
are arguably the most physiologically relevant model sys-
tems, but which generally cannot be obtained on the scale
required for HTS.
EXPERIMENTAL PROCEDURES
Fabrication of Microfluidic Chips
The microfluidic device (Figure 1A) was fabricated by patterning 75 mm deep
channels into poly(dimethylsiloxane) (PDMS) by using soft lithography (SquiresChemistry & Biologyand Quake, 2005). The PDMS was activated by incubation for 3 min in an
oxygen plasma (Plasma Prep 2, Gala Instrumente) and was bound to
a 50 mm 3 75 mm glass slide (Fisher Bioblock). Inlets and outlets were
made by using 0.75 mm diameter biopsy punches (Harris Uni-Core). The
channels were flushed with a commercial surface-coating agent (Aquapel,
PPG Industries) and, subsequently, with N2 prior to use.
Cells
HEK293T cells were grown and encapsulated in DMEM medium (GIBCO-
BRL), and Jurkat cells were grown and encapsulated in RPMI medium
(GIBCO-BRL). Both media were supplemented with 10% fetal bovine serum
(GIBCO-BRL) and 1% penicillin/streptomycin (GIBCO-BRL). Cells were incu-
bated at 37C under a 5% CO2 atmosphere saturated with water.
For fluorescence readouts, the lacZ gene was introduced into HEK293T
cells by retroviral transduction as described elsewhere (Stitz et al., 2001). In
brief, by transfecting HEK293T cells, we generated murine leukemia virus-
derived particles (pseudotyped with the G protein of the vesicular stomatitis
virus) that had packaged a vector encoding lacZ. Two days after transfection,
the particles were harvested from the cell-culture supernatants and were used
for transduction of fresh HEK293T cells during 1 hr of incubation. Subse-
quently, the cells were cultivated for 2 wk before encapsulating them together
with 1.7 mM fluorescein di-b-D-galactopyranoside (FDG, Euromedex) in drops.
Synthesis of Surfactants
Detailed synthesis and characterization of fluorinated surfactants will be
published elsewhere by A.E. and C.H. (unpublished data). In brief, surfactants
(Figure 2) were synthesized as follows:
Carboxy-PFPE
To obtain the ammonium salt of carboxy-PFPE, Krytox FS(L) 2000 (DuPont)
was reacted with NH4OH as described (Johnston et al., 1996).
DMP-PFPE
Synthesis of the hydrophilic head group dimorpholinophosphate (DMP) was
carried out by reaction of PhEtOH (Aldrich), POCl3 (Fluka), and morpholine
(Fluka) with (Et)3N (Sigma-Aldrich) in THF (Fluka) on ice. Subsequently, DMP
was coupled to water/cyclohexane/isopropanol-extracted Krytox FS(H) 4000
(DuPont) by Friedels-Craft-Acylation.
PEG-PFPE
Reaction of Krytox FS(H) 4000 (DuPont) with polyethyleneglycol (PEG) 900
(Sigma) resulted in a mixture of PEG molecules coupled to either one or two
PFPE molecules.
Poly-L-Lysine-PFPE
Krytox FS(L) 2000 (DuPont) was reacted with poly-L-Lysine (15,000–30,000;
Sigma).
Biocompatibility Test for Different Surfactants
A 100 ml suspension of HEK293T cells (1.5 3 106 cells/ml in fresh media) was
seeded on top of a layer of perfluorocarbon oil (FC40, 3M) in the presence
(0.5% w/w) and absence of the tested surfactants. After incubation at 37C
for 0 hr, 24 hr, and 48 hr, bright-light images were taken with a Leica DMIRB
microscope.
Drop-Based Encapsulation, Cell Recovery, and Live/Dead Staining
Cells were adjusted to a density of 2.5 3 106 cells/ml (determined with a
Neubauer counting chamber), stirred at 200 rpm by using an 8 mm magnetic
stir-bar (Roth) in a 5 ml polyethylene syringe (Fisher Bioblock), and injected
via PTFE tubing (0.56 mm 3 1.07 mm internal/external diameter, Fisher Bio-
block) into the microfluidic device (Figure 1A) by using a syringe pump (PHD
2000, Harvard Apparatus) at a flow rate of 1000 ml/hr. The cell suspension
was diluted on-chip (see below) by diluting it with sterile media (1000 ml/hr if
not otherwise stated), and drops were generated by flow focusing (Anna
et al., 2003) of the resulting stream with perfluorinated oil (FC40, 3M), contain-
ing 0.5% (w/w) DMP-PFPE (4000 ml/hr). The drop volume was calculated by
dividing the flow rate by the drop frequency (determined by using a Phantom
V4.2 high-speed camera). Experimental variations in the drop frequency (at
constant flow rates) were defined as the degree of polydispersity in terms of
the volume (corresponding to the third power of the polydispersity in terms
of the diameter when considering a perfect sphere). For each sample, 500 ml
of the resulting emulsion was collected within a 15 ml centrifuge tube and15, 427–437, May 2008 ª2008 Elsevier Ltd All rights reserved 435
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Cells in Dropsincubated at 37C within a CO2 incubator (5% CO2, saturated with H2O). After
incubation, 250 ml of the emulsion was transferred into a new centrifuge tube
and broken by the addition of 15% Emulsion Destabilizer A104 (RainDance
Technologies; Guilford, CT) and 10 ml live/dead staining solution (LIVE/
DEAD Viability/Cytotoxicity Kit for animal cells, Invitrogen Kit L-3224) and sub-
sequent mixing. After incubation for 3 min (to allow sedimentation of the oil
phase), the supernatant was transferred into a 25 cm2 tissue-culture flask
and incubated for 1 hr at room temperature.
On-Chip Dilution of Cells
Drops were generated and diluted on-chip by bringing together two channels
containing the cell suspension and sterile media, respectively, and varying the
relative flow rates while keeping the overall aqueous flow rate constant at 2000
ml/hr by using two syringe pumps. The number of cells per drop was deter-
mined by evaluating movies taken with a high-speed camera (Phantom V4.2)
mounted on a microscope. For each dilution, 120 drops were analyzed to
determine the number of cells per drop. Subsequently, the data were fitted
to a Poisson distribution (p[x = k] = e
l 3 lk/k!) by using XmGrace (http://
plasma-gate.weizmann.ac.il/Grace/).
Reinjection of Emulsions and Fluorescence
Readout of Individual Samples
The emulsions were collected in open syringes (without the plunger being
inserted) and incubated within a water-saturated atmosphere (37C, 5%
CO2). During the encapsulation step, a laser beam (488 nm wavelength) was
focused onto the channel by using an objective with a 40-fold magnification
(Figure 6D, downstream of the nozzle) to excite the fluorophor. Emitted light
was diverted by a dichroic mirror (488 nm notch filter), filtered (510 nm ±
10 nm), and collected in a photomultiplier to record the first fluorescence mea-
surement (t0). After the desired incubation time, mineral oil was added to fill the
syringe completely before inserting the plunger and reinjecting the emulsion
together with 0.5% w/w DMP-PFPE surfactant in FC40 (injected into the oil
inlet to space out the drops) into a chip with the same design as for the encap-
sulation step. To avoid fragmentation of the drops before the second fluores-
cence measurement (at ti), the flow direction was reversed compared to the
encapsulation step (the emulsion was injected into the outlet [Figure 1A] to
avoid branching channels). All signals from the photomultiplier were recorded
by using Labview (National Instruments) and by running an in-house program
for the data analysis.
Plug-Based Encapsulation, Cell Recovery, and Live/Dead Staining
To prepare the plugs, 5 3 106 cells/ml (determined with a Neubauer counting
chamber) were stirred at 510 rpm within a 1.8 ml cryotube (Nunc) by using an
8 mm magnetic stir-bar (Roth) and were kept at 4C. Subsequently, 660 nl
plugs of this cell suspension and perfluorinated oil (FC40, 3M) were aspirated
(at 500 ml/hr) into PTFE tubing (0.56 mm3 1.07 mm internal/external diameter,
Fisher Bioblock) in an alternating fashion by using a syringe pump (PHD 2000,
Harvard Apparatus). For each sample, 30 plugs were loaded before the tubing
was sealed (by clamping microtubes to both ends) and were incubated at 37C
within a CO2 incubator (5% CO2, saturated with H2O). After incubation, the
plugs were infused into a 25 cm2 tissue-culture flask. Subsequently, 4 ml
live/dead staining solution (LIVE/DEAD Viability/Cytotoxicity Kit for animal
cells, Invitrogen Kit L-3224) was added, and the samples were incubated for
1 hr at room temperature. When using adherent cells, the staining solution
was additionally supplemented with 0.25 g/l trypsin (GIBCO-BRL) to break
up cell clumps.
Determination of the Survival Rates and Total Recovery
After staining, live and dead cells were counted manually by using a micro-
scope (Leica DMIRB) with a UV-lightsource (LEJ ebq 100). For each sample
within a 25 cm2 tissue-culture flask, 30 fields of view (corresponding to
4.2 mm2) were evaluated to calculate the total number of living (green stain)
and dead (red stain) cells.
Encapsulation of C. elegans
Eggs were resuspended in M9 minimal media (Sigma) supplemented with
E. coli OP50 (10% w/v of pelleted bacteria). Plugs of the resulting suspension
were aspirated into PTFE tubing and incubated at room temperature.436 Chemistry & Biology 15, 427–437, May 2008 ª2008 Elsevier LtdRecultivation Experiments
For recultivation of cells recovered from drops or plugs, semiconditioned
medium supplemented with 30% fetal bovine serum (GIBCO-BRL) was added
to the cells instead of the staining solution. Cells were then incubated for 2 d at
37C within a CO2 incubator (5% CO2, saturated with H2O) before imaging with
bright-field microscopy.
SUPPLEMENTAL DATA
Supplemental Data include movies of cell encapsulation, the incubation of
C. elegans in aqueous plugs, and the reinjection of an emulsion and are
available at http://www.chembiol.com/cgi/content/full/15/5/427/DC1/.
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